CN100409757C - 调脂稳压保健茶的制备方法 - Google Patents
调脂稳压保健茶的制备方法 Download PDFInfo
- Publication number
- CN100409757C CN100409757C CNB2005100812541A CN200510081254A CN100409757C CN 100409757 C CN100409757 C CN 100409757C CN B2005100812541 A CNB2005100812541 A CN B2005100812541A CN 200510081254 A CN200510081254 A CN 200510081254A CN 100409757 C CN100409757 C CN 100409757C
- Authority
- CN
- China
- Prior art keywords
- parts
- fat
- preparation
- leaf
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 241001122767 Theaceae Species 0.000 title description 32
- 240000000249 Morus alba Species 0.000 claims abstract description 25
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 25
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 21
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 21
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 17
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 15
- 230000036772 blood pressure Effects 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 13
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 13
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 13
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 13
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 13
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 13
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 13
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 13
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 13
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 13
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 13
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 9
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 9
- 235000008113 selfheal Nutrition 0.000 claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims abstract 4
- 244000028550 Auricularia auricula Species 0.000 claims description 8
- 235000000023 Auricularia auricula Nutrition 0.000 claims description 8
- 230000000087 stabilizing effect Effects 0.000 claims description 8
- 238000009738 saturating Methods 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000218628 Ginkgo Species 0.000 claims 5
- 230000036541 health Effects 0.000 abstract description 28
- 244000194101 Ginkgo biloba Species 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000035622 drinking Effects 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 244000020551 Helianthus annuus Species 0.000 abstract description 3
- 235000003222 Helianthus annuus Nutrition 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 2
- 235000013361 beverage Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 206010020772 Hypertension Diseases 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241001506047 Tremella Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- -1 former Hu Luobu Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002799 interferon inducing agent Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical group C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CPGCVOVWHCWVTP-LJAQVGFWSA-N (S)-nonacosan-10-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)CCCCCCCCC CPGCVOVWHCWVTP-LJAQVGFWSA-N 0.000 description 1
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 101100256850 Drosophila melanogaster EndoA gene Proteins 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010020590 Hypercalciuria Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 244000062250 Kaempferia rotunda Species 0.000 description 1
- 235000013422 Kaempferia rotunda Nutrition 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- CPGCVOVWHCWVTP-UHFFFAOYSA-N celidoniol Natural products CCCCCCCCCCCCCCCCCCCC(O)CCCCCCCCC CPGCVOVWHCWVTP-UHFFFAOYSA-N 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010159 dioecy Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229930182487 phenolic glycoside Natural products 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 244000209700 shan ge teng Species 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于保健饮料的改进，特别是调脂稳压保健茶的制备方法，其中各原料的重量配比为：桑叶300-600、山楂9-11、木耳13-17、香菇15-19、决明子13-17、葛根8-12、夏枯草8-12、银杏叶4-8、向日葵果盘18-22，按配料组分重量比称取上述原料，除桑叶和银杏叶外，将其他的7种原料用水煎熬15-25分钟后，再加入银杏叶煎熬4-6分钟，将煎熬好的药汁倒入盛桑叶的器皿中，待桑叶被药汁浸泡透后，将桑叶烘干，然后计量、包装、出厂。长期饮用不仅可以增加营养、保健身体、调整血脂、平稳血压，而且成本低，原料来源广泛，制作简易，饮用可口。
Description
技术领域
本发明属于保健饮料的改进，特别是调脂稳压保健茶的制备方法。
背景技术
随着社会迅猛发展和人们生活水平不断的提高，人们对健康的要求水平也越来越高。由于生活节奏的加快和社会竞争压力的增大，“亚健康”现象越明显。虽然当今的医疗水平已大大提高，但心、脑血管疾病死亡率还是很高的。预防和减少心脑血管疾病，增强体质，促进健康尤为重要。
发明内容
本发明的目的在于提供一种调脂稳压保健茶的制备方法，长期饮用该保健茶不仅可以增加营养、保健身体、调整血脂、平稳血压，而且成本低，原料来源广泛，制作简易，饮用可口。
本发明的目的是这样实现的：一种调脂稳压保健茶的制备方法，有如下步骤：1、按配料组分重量比称取原料，(用量为重量份)桑叶300-600、山楂9-11、木耳13-17、香菇15-19、决明子13-17、葛根8-12、夏枯草8-12、银杏叶4-8、向日葵果盘18-22；将山楂、香菇、葛根、向日葵果盘切片；2、除桑叶和银杏叶外，将其它的7种原料用水煎熬15-25分钟后，再加入银杏叶煎熬4-6分钟；3、将煎熬好的药汁倒入盛桑叶的器皿中，将桑叶浸泡透；4、将浸泡透的桑叶烘干，烘干温度为40℃-80℃，计量、包装、出厂。
本发明保健茶制备方法配方的优选重量(份)配比范围是：桑叶400-500、山楂9.5-10.5、木耳14-16、香菇16-18、决明子14-16、葛根9-11、夏枯草9-11、银杏叶5-7、向日葵果盘19-21。
本发明保健茶制备方法配方的最佳重量(份)配比范围是：桑叶400、山楂10、木耳15、香菇17、决明子15、葛根10、夏枯草10、银杏叶6、向日葵果盘20。
本发明制备方法生产的保健茶为无茶叶配方的保健茶。在古代医书中也有收入无茶叶配方的药茶方剂，如：据南朝梁陶弘景《神农本草经集注》记载：“西阳、武昌、庐江、晋陵皆有好茗，饮之宜人。凡似引物，我茗的及木叶、天门冬苗、菝葜皆易人，南方有瓜芦，亦似茗也。”这里说的“茶”并非是局限于茶叶，与茶水相似的汤饮，也被称为茶。
桑叶：属桑科植物树上的树叶，味苦、甘、性寒。功效：疏散风热，平肝阳，明目凉血。主治：外感风热，发热，头痛，咳嗽。肝阳上亢引起的头晕目眩，头胀、头痛。风热或干火所致之目赤肿痛，血热之吐血等。
山楂：本品内含糖类、维生素、原胡罗卜、脂肪、蛋白质、淀粉、苹果酸、枸橼酸、钙和铁等物质，特别是维生素C的含量极为丰富，叶水煎茶饮，可降血压；根治风湿性关节痛，痢疾、水肿。现代药理研究认为，山楂含有大量的维生素C和酸类物质，具有促进胃液分泌，增加胃内酵素作用。还可扩张冠状动脉，舒张血管，增加冠状动脉的血流量，改善心肌活力，兴奋中枢神经系统，具有降血脂、降血压、强心和抗心律不齐等作用，临床用于治疗高血压，老年性心脏衰弱，冠心性高血症。
木耳：黑木耳与白木耳所含成分大致相近，据分析二者含脂肪、蛋白质、多糖类、灰分。灰分中含有磷、硫、铁、镁、钙、钾及钠等，另据报道，白木耳含甘露醇、多缩戎糖，麦角甾醇，海藻糖。
功用：滋养益胃。和血养营，主治崩中漏下，痔疮出血。适用于高血压、便秘等，白木耳为珍贵滋养品，适用于高血压、血管硬化等症。
香菇：香菇含蛋白质13％、碳水化合物54％，含相当丰富的钾，丰富的核黄素、尼g酸、钙、镁、铁、锰、磷，还含有多糖类物质，干扰素诱导剂以及维生素D原(麦甾醇)等有益成分。香菇所含干扰素诱导体内干扰素产生的和肝脏中胆固醇增加，促进血液循环，有防止动脉硬化和血管变脆及降血压作用。其所含的麦甾醇，经人体吸收后可转化为维生素D2，有助婴幼儿骨骼发育，防止佝偻病和贫血。经科学家们的研究分析，香菇具有良好的抗癌作用，香菇所含的香菇多糖，对小鼠肉瘤有很强的抑制作用，其抑制肿瘤的作用与其能增强机体的细胞免疫和体液免疫功能有关，香菇中不含有1，3-B-葡萄糠苷酶，能提高机体抑制肿瘤的能力，间接灭癌细胞，防止癌细胞扩散。
决明子：种子含大黄素、钝叶决明素、大黄粉、大黄酚蒽酮、芦荟大黄素、大黄酸。叶含山奈酚-3-双葡萄糖苷、葫芦巴碱、水苏碱及甜菜碱。根含蒽醌，无色天竺葵啶、胆碱及B-谷甾醇，花含山奈酚苷。茎、荚均含有葫芦巴碱、胆碱及甜草碱。
药理：1、种子水、醇浸注对麻醉动物有降低血压和利尿作用，能降低血清胆固醇。2、因含蒽醌类物质，有缓泻作用。3、抑菌作用：对结核杆菌、葡萄球菌、常见的皮肤真菌及白喉、伤寒、副伤寒、大肠杆菌有抑制作用。
葛根：属豆科植物野生葛藤的肥大块根。富含淀粉，可磨葛粉，供食用，根、茎均作药用。性味：甘、平、辛、无毒。成分：根，含有淀粉，供药用成分为异黄酮类化合物，黄酮甙，葛根素和7-木糖-葛根素等。近来研究证明，葛根黄酮的主要成分为葛根素和大豆黄酮甙。叶：含有腺嘌呤、氨基酸。药理：葛根总黄酮能增加冠状动脉的血流量，降低心肌耗氧罩，对脑血管有一定的扩张作用，对垂体后叶激素引起的急性心肌缺血的保护作用，且对脑血管和外周血管均有扩张作用，此可能是葛根缓解高血压和肢麻的原因之一。
夏枯草：花穗含枯草苷(prunellin)、熊果酸和齐墩果酸、花色苷。花含矢车名菊素。叶含金丝桃苷、芸香苷。种子含脂肪油及鲜脂酶(lipase)。全草含管挥油，主成分为a樟脑、小茴香酮、维生素B1、水溶无机盐类(约3.5％)，以及少量生物碱和咖啡酸。
药理：1、水及水醇浸液的降低麻醉动物血压作用：对在位兔心小剂量兴奋，收缩振幅增大，大剂量的则抑制；对蟾蜍下肢血管管流有舒张的作用。2、可使家兔体子宫出现强直性收缩，肠蠕动增强；3、有利尿的作用；4、对Hela细胞有细胞毒作用，对汪鼠的肉瘤S-180抑制率为40％-50％。5、对葡萄球菌、链球菌、肺炎双球菌、霍乱弧菌等有较强的抗癌作用。6、水浸液对多种皮肤真菌、埃柯病毒有一定抑制作用。
银杏叶：银杏又名白果，银杏为落叶乔木，雌雄异株，叶片呈扇形。银杏叶含有胡罗卜素、硫胺素、核黄素、银杏酸、银杏醇、氢化白果酸等成分。银杏叶有降低血清胆固醇、扩张冠状动脉作用，近年来用于治疗高血压、冠心病、心绞痛、脑血管痉挛、血清胆固醇过高症等有一定效果。
向日葵果盘：向日葵为一年生草本植物，其种子称葵花籽，葵花籽长在圆盘形的果盘上。向日葵功用：平肝祛风，清湿热，消滞气。种子油可用软膏的基础药，茎髓为利尿消炎剂；叶与花瓣可作苦味健胃剂。果盘(花托)有降血压作用。
由于本发明保健茶的制备方法生产出的保健茶，经粉碎，混匀，装入纤维纸袋中，放入杯内用沸水冲泡萃取，使本发明保健茶配方组份中的有益成分分离出来，经长时间饮用后，其有效成分在人体内可以达到量化标准，起到滋阴、益血、抑制自由基、增强免疫力、补充矿物质的功效，达到增进营养，促进健康和预防疾病的目的。
为表明本发明制备方法生产的保健茶对人体调整血脂、平稳血压的保健作用，本发明经222例系统临床观察，222例观察对象均为高血压、高血脂，并具有不同程度的头痛、头晕等症状。年龄：35岁-71岁，性别：男186例，女36例。
年龄分组 表1
| 35岁-40岁 | 41岁-50岁 | 51岁-60岁 | 61岁-71岁 | 合计 |
| 26例 | 61例 | 60例 | 75例 | 222例 |
饮用剂量方法：
本发明制备方法生产的保健茶每100g为一大袋，每大袋分成6小袋。观察对象每人每天一小袋，用开水冲泡后饮用，饮用后可继续用开水冲泡，在一日内泡到无味后为止，待第二天按上述剂量和方法连续饮用30天。
临床观察结果：
本观察对象在饮用本发明制备方法生产的保健茶期间均未服用治疗高血压、高血脂的药剂，经饮用本发明制备方法生产的保健茶30天后，血脂和血压都有一定的变化。表2为222例观察对象饮用本发明制备方法生产的保健茶前、后血脂、血压变化情况。
表2
222例观察对象经饮用本发明制备方法生产的保健茶30天后，血脂和血压都有不同程度下降，原有头痛、头晕等症状都有不同程度的好转。
表3为222例饮用本发明制备方法生产的保健茶前、后血脂对比表。
表3
注：四项是指：TG、CHO、HDL、LDL
表3的数据表明，222例引用本发明制备方法生产的保健茶30天后，血脂明显下降，222例血脂达到正常范围的有效率为84.68％。
本发明制备方法生产的保健茶的配料均为一般普通常用食物和中草药，他们是无毒的绿色食物，在自然界产量大，来源广、易收集、成本低。本保健茶制作容易，携带方便，饮用方便，不拘时间，随泡随饮，自然芳香，饮用可口，是一种保健身体、预防高血压、高血脂病症的理想饮茶。
具体实施方式
一种调脂稳压保健茶的生产方法如下：
按配料重量配比称取原料(千克)桑叶40、山楂1、木耳1.5、香菇1.7、决明子1.5、葛根1、夏枯草1、银杏叶0.6、向日葵果盘2，将山楂、香菇、葛根、向日葵果盘切片；除桑叶和银杏叶外，将其它的7种原料用水煎熬25分钟后，再加入银杏叶煎熬5分钟；将煎熬好的药汁倒入盛桑叶的器皿中，待桑叶被药汁浸泡透后，将桑叶烘干，烘干温度为60℃，然后计量、包装、出厂。
Claims (3)
1. 一种调脂稳压保健茶的制备方法，其特征是有如下步骤：(1)、按配料组分重量比称取原料，桑叶300-600、山楂9-11、木耳13-17、香菇15-19、决明子13-17、葛根8-12、夏枯草8-12、银杏叶4-8、向日葵果盘18-22；将山楂、香菇、葛根、向日葵果盘切片；(2)、除桑叶和银杏叶外，将其它的7种原料用水煎熬15-25分钟后，再加入银杏叶煎熬4-6分钟；(3)、将煎熬好的药汁倒入盛桑叶的器皿中，将桑叶浸泡透；(4)、将浸泡透的桑叶烘干，烘干温度为40℃-80℃，计量、包装、出厂。
2. 根据权利要求1所述的调脂稳压保健茶的制备方法，其特征是：其中各原料的重量配比是：桑叶400-500、山楂9.5-10.5、木耳14-16、香菇16-18、决明子14-16、葛根9-11、夏枯草9-11、银杏叶5-7、向日葵果盘19-21。
3. 根据权利要求1所述的调脂稳压保健茶的制备方法，其特征是：其中各原料的重量配比是：桑叶400、山楂10、木耳15、香菇17、决明子15、葛根10、夏枯草10、银杏叶6、向日葵果盘20。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100812541A CN100409757C (zh) | 2005-06-23 | 2005-06-23 | 调脂稳压保健茶的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100812541A CN100409757C (zh) | 2005-06-23 | 2005-06-23 | 调脂稳压保健茶的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1709165A CN1709165A (zh) | 2005-12-21 |
| CN100409757C true CN100409757C (zh) | 2008-08-13 |
Family
ID=35705502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100812541A Expired - Fee Related CN100409757C (zh) | 2005-06-23 | 2005-06-23 | 调脂稳压保健茶的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100409757C (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102415528B (zh) * | 2011-12-13 | 2013-04-03 | 甘肃赫原生物制品有限公司 | 木糖醇保健口服液及其制备方法 |
| CN104687176A (zh) * | 2015-02-10 | 2015-06-10 | 叶节和 | 一种植物饮料及其制备方法 |
| CN105030950B (zh) * | 2015-08-06 | 2019-01-18 | 山东凤凰生物有限公司 | 防治高血脂的微生态制剂及其制备方法和应用 |
| CN105770098A (zh) * | 2016-03-17 | 2016-07-20 | 天津元恒德科技有限公司 | 一种具有降血压的组合物及应用 |
| CN107164189A (zh) * | 2017-06-27 | 2017-09-15 | 何秋容 | 降压保健酒的制作方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1354000A (zh) * | 2000-11-21 | 2002-06-19 | 黄涛 | 一种瘦身减肥茶及其制作方法 |
| CN1087174C (zh) * | 1999-04-19 | 2002-07-10 | 郭立文 | 一种降糖降脂的保健茶 |
| CN1183943C (zh) * | 2002-12-03 | 2005-01-12 | 郭志忠 | 一种含有降血压降血脂中草药的茶 |
-
2005
- 2005-06-23 CN CNB2005100812541A patent/CN100409757C/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087174C (zh) * | 1999-04-19 | 2002-07-10 | 郭立文 | 一种降糖降脂的保健茶 |
| CN1354000A (zh) * | 2000-11-21 | 2002-06-19 | 黄涛 | 一种瘦身减肥茶及其制作方法 |
| CN1183943C (zh) * | 2002-12-03 | 2005-01-12 | 郭志忠 | 一种含有降血压降血脂中草药的茶 |
Non-Patent Citations (1)
| Title |
|---|
| 调节血脂保健食品的研究进展. 何洪英等.食品与机械，第1期. 2001 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1709165A (zh) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN103891513A (zh) | 富硒富锌玛卡种植方法及其制品 | |
| Hussain et al. | Fig (Ficus Carica)—Morphology, taxonomy, composition and health benefits | |
| KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
| KR20090032158A (ko) | 가압전이(加壓轉移)에 의한 과일 침출 및 액상 차 조성물과 그 제조방법 | |
| CN106615431A (zh) | 一种菊芋片茶及其制作方法 | |
| CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
| CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
| KR20100082689A (ko) | 월드 인삼 조성물과 그 제조방법 | |
| KR20130133946A (ko) | 한약재를 포함하는 된장 및 그의 제조방법 | |
| Leyel | Herbal delights | |
| JP3213508U (ja) | 体質改善効果を高めた食物用生薬材料及びこれを入れた体質改善用主食材料と副食材料 | |
| CN100409757C (zh) | 调脂稳压保健茶的制备方法 | |
| KR20130137066A (ko) | 동아 막걸리 제조방법 | |
| CN103602564A (zh) | 甜玉米灵芝酒及其制备方法 | |
| Eliseeva et al. | Yarrow (lat. Achillea) | |
| KR101479228B1 (ko) | 옥수수 감자 백숙의 제조방법 및 그 백숙 | |
| CN107156829A (zh) | 一种适用于肝病患者的全营养配方食品 | |
| Mars | Dandelion medicine: remedies and recipes to detoxify, nourish, and stimulate | |
| Ye et al. | Traditional Chinese dates (Jujubes)-based functional foods in Chinese history | |
| Kishor et al. | Wild food plants of Himachal pradesh: a review | |
| CN108142567A (zh) | 油莎豆果蔬冲剂及其制备方法和油莎豆果蔬饮品 | |
| KR20100072143A (ko) | 월드 인삼 조성물과 그 제조방법 | |
| KR20100082688A (ko) | 월드 홍삼 조성물과 그 제조방법 | |
| CN104721248B (zh) | 具有抗抑郁作用的组合物及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080813 Termination date: 20140623 |
|
| EXPY | Termination of patent right or utility model |